首页 | 本学科首页   官方微博 | 高级检索  
检索        

Fas配体阳性睾丸细胞和环孢素A对移植胰岛细胞存活起协同保护作用
作者姓名:Chen CQ  Zhan WH  Wang JP  Cai SR  He D  Wu XJ  Lan P
作者单位:510080,广州,中山大学附属第一医院胃肠胰外科
基金项目:国家自然科学基金资助项目 ( 3 9770 72 6),中山医科大学科研启动基金资助项目 ( 2 0 0 0 2 7)
摘    要:目的 探讨Fas配体 (FasL)阳性睾丸细胞与胰岛细胞共移植后联用环孢素A(CsA)对移植胰岛细胞存活的协同保护作用。 方法 将同种大鼠胰岛细胞与睾丸Sertoli细胞同侧或异侧共移植于 4 1只糖尿病SD大鼠受体肾包膜下。实验大鼠分 7组 ,术后酌用CsA ,观察各组大鼠移植物存活情况。 结果 单纯胰岛细胞移植 (对照组 )后胰岛细胞的平均存活期为 (4 6± 1 1)d ,加用CsA存活期明显延长至 (2 1 8± 4 7)d(P <0 0 1)。与 1× 10 7个睾丸细胞同侧共移植的胰岛细胞平均存活期超过 (5 7 5± 4 0 )d ,但如移植前先封闭睾丸细胞表达的FasL后 ,移植的胰岛细胞平均存活期缩短为(5 8± 2 6 )d。胰岛细胞与 1× 10 5个睾丸细胞分别共移植于两侧肾包膜下 ,术后联用CsA ,胰岛细胞的平均存活期超过 (5 5 0± 6 5 )d ,与 1× 10 7个睾丸细胞同侧共移植的存活期相近 ,但比对照组或CsA组则显著延长 (P <0 0 1)。当胰岛细胞与 1× 10 6个睾丸细胞分别共移植且不用CsA时 ,胰岛细胞存活期平均仅为 (11 5± 3 1)d ,但仍较对照组延长 (P <0 0 5 )。 结论 表达FasL的睾丸细胞与CsA联用后可通过不同机制抑制胰岛细胞移植排斥反应而起到全身的协保护作用。

关 键 词:Fas配体  阳性睾丸细胞  环孢素A  移植  胰岛细胞  保护作用  细胞存活
修稿时间:2003年3月11日

Synergistic protective effect of testicular cells expressing Fas ligand and cyclosporine A on the survival of islet allografts
Chen CQ,Zhan WH,Wang JP,Cai SR,He D,Wu XJ,Lan P.Synergistic protective effect of testicular cells expressing Fas ligand and cyclosporine A on the survival of islet allografts[J].Chinese Journal of Surgery,2003,41(11):845-848.
Authors:Chen Chuang-qi  Zhan Wen-hua  Wang Jian-ping  Cai Shi-rong  He De  Wu Xiao-jian  Lan Ping
Institution:Department of Gastrointestinal and Pancreatic Surgery, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China.
Abstract:OBJECTIVE: To explore the synergistic protective effect of co-transplanted testicular cells expressing FasL and CsA on survival of islet allografts. METHODS: The allogeneic islets and testicular cells were co-transplanted into the renal subcapsular space of the diabetic recipients with or without CsA after operation. Allografts survival period and the testicular cells or islets function were analyzed. RESULTS: The mean survival period of control group was 4.6 +/- 1.1 days. When CsA was administered after transplantation, the mean survival period of islet allografts, (21.8 +/- 4.7) days, was significantly longer than that of control group (P < 0.01). When islets were co-transplanted together with 1 x 10(7) testicular cells (group A), a significant prolongation of graft survival was found (more than 57.5 +/- 4.0 days; P < 0.01 vs. control). But if 1 x 10(7) testicular cells expressing FasL were cultured with FasL-mAb for 30 minutes before co-transplantation (group B), the mean survival period of islet allografts (5.8 +/- 2.6 days), was similar to that in control group, but significantly shorter than that in group A (P < 0.01). When islets and 1 x 10(5) testicular cells were co-transplanted separately into the bilateral renal subcapsular space with CsA (group C), the survival of islet allografts was significantly prolonged in comparison with control group (more than 55.0 +/- 6.5 days; P < 0.01 vs. control), and similar to islets co-transplanted together with 1 x 10(7) testicular cells (group A). When islets were co-transplanted separately with 1 x 10(6) testicular cells without CsA (group D), the mean survival period (11.5 +/- 3.1 days) was shorter than that in group C, but prolonged in comparison to control group (P < 0.05). CONCLUSION: The co-transplanted testicular cells expressing FasL with administering CsA post-transplantation can jointly inhibit immune rejection of islet allografts by different mechanism and play a systemic and synergistic protective role to islet allografts.
Keywords:Islet of Langerhans transplantation  Sertoli cells  Fas ligand  Immune privilege  Cyclosporine A
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号